Fibrin Fibrinogen Degradation Products
"Fibrin Fibrinogen Degradation Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis.
| Descriptor ID |
D005338
|
| MeSH Number(s) |
D12.776.124.270.300 D12.776.811.300.290
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrin Fibrinogen Degradation Products".
Below are MeSH descriptors whose meaning is more specific than "Fibrin Fibrinogen Degradation Products".
This graph shows the total number of publications written about "Fibrin Fibrinogen Degradation Products" by people in this website by year, and whether "Fibrin Fibrinogen Degradation Products" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrin Fibrinogen Degradation Products" by people in Profiles.
-
Bansal A, Singh AD, Jain V, Aggarwal M, Gupta S, Padappayil RP, Nadeem M, Joshi S, Mian A, Greathouse T, Wells D, Gupta M, Khan MZ. The association of D-dimers with mortality, intensive care unit admission or acute respiratory distress syndrome in patients hospitalized with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Heart Lung. 2021 Jan - Feb; 50(1):9-12.
-
McKee RS, Tarr PI, Dietzen DJ, Chawla R, Schnadower D. Clinical and Laboratory Predictors of Shiga Toxin-Producing Escherichia coli Infection in Children With Bloody Diarrhea. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):e116-e122.
-
Williams KL, Woslager M, Garland SL, Barton RP, Banner W. Use of polyvalent equine anti-viper serum to treat delayed coagulopathy due to suspected Sistrurus miliarius streckeri envenomation in two children. Clin Toxicol (Phila). 2017 Jun; 55(5):326-331.
-
Douketis JD, Ginsberg JS, Haley S, Julian J, Dwyer M, Levine M, Eisenberg PR, Smart R, Tsui W, White RH, Morris TA, Kaatz S, Comp PC, Crowther MA, Kearon C, Kassis J, Bates SM, Schulman S, Desjardins L, Taillefer R, Begelman SM, Gerometta M. Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thromb Res. 2012 Sep; 130(3):381-9.
-
Stein PD, Sostman HD, Bounameaux H, Buller HR, Chenevert TL, Dalen JE, Goodman LR, Gottschalk A, Hull RD, Leeper KV, Pistolesi M, Raskob GE, Wells PS, Woodard PK. Challenges in the diagnosis of acute pulmonary embolism. Am J Med. 2008 Jul; 121(7):565-71.
-
Rathbun SW, Whitsett TL, Raskob GE. Exclusion of first-episode deep-vein thrombosis after-hours using D-dimer. Blood Coagul Fibrinolysis. 2007 Dec; 18(8):795-800.
-
Rathbun SW, Whitsett TL, Raskob GE. Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial. Ann Intern Med. 2004 Dec 07; 141(11):839-45.
-
Rathbun SW, Whitsett TL, Vesely SK, Raskob GE. Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest. 2004 Mar; 125(3):851-5.
-
Comp PC. Animal studies of protein C physiology. Semin Thromb Hemost. 1984 Apr; 10(2):149-53.